EF
DGX icon

Empowered Funds’s Quest Diagnostics DGX Stock Holding History

Empowered Funds’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8,155
Closed -$1.28M – 570
2022
Q4 		$1.28M Buy
+8,155
New +$1.17M 0.08% 231

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Empowered Funds's DGX Position: Q2 2026 in Review

Empowered Funds increased its Quest Diagnostics (DGX) stake by 11% in Q2 2026, buying an estimated $198K and bringing the position to 10,624 shares worth $2.25M. The position accounts for 0.01% of the portfolio, ranked #1122.

Empowered Funds first reported a position in DGX in Q4 2020 and has held it in 22 quarters since. The position peaked at $5.59M in Q4 2021. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Empowered Funds held 10,624 shares of Quest Diagnostics worth $2.25M as of Q2 2026.
  • Empowered Funds bought 1,010 Quest Diagnostics shares in Q2 2026, an estimated $198K.
  • Quest Diagnostics made up 0.01% of Empowered Funds's portfolio in Q2 2026, its #1122 holding.
  • Empowered Funds first reported a position in Quest Diagnostics in Q4 2020 and has held it in 22 quarters since.
  • Empowered Funds's Quest Diagnostics position peaked at $5.59M in Q4 2021.
  • 1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.